The Modern methods of obesity treatment - review of the literature
DOI:
https://doi.org/10.12775/QS.2023.13.01.006Keywords
GLP-1, obesity, obesity treatmen, diagnosis of obesity, obesity risk factors, liraglutyd, semaglutydAbstract
Introduction and aim of the study: Obesity is not only increases the risk of developing other diseases, but is itself a chronic disease. It is characterized by a lack of tendency to spontaneous resolution and a tendency to relapse. The growing number of patients facing obesity and its consequences prompts the search for newer and newer methods of its treatment. The aim of this paper is to discuss modern methods of obesity therapy, aimed at reducing the risk of its consequences, both health, psychological, social and economic.
Methods and materials: This literature review is based on articles published in the PubMed database from 2016 to 2023, using the following phrases: "obesity risk factors", "obesity treatment", "diagnosis of obesity", "GLP -1 obesity".
State of knowledg: We now know that obesity is a disease that needs to be treated. The goal of therapy is not only to achieve the target body weight, but also to reduce the risk of disease and improve the control of coexisting diseases.
Conclusion: Obesity is a disease that requires interdisciplinary treatment based on behavioral therapy including changing the lifestyle to a healthier one, psychological support and pharmacological, and in some cases, surgical treatment.
References
World Health Organization: Obesity and overweight. 9.06.2021. https://www.who.int/
news room/fact sheets/detail/obesity and overweight (dostęp: 22.04.2023r.]
Centrum Badania Opinii Społecznej: Czy Polacy mają problem z nadwagą. Komunikat
z badań. 08.2019. https://www.cbos.pl/SPISKOM.POL/2019/K_103_19.PDF (dostęp:
04.2023r.)
Lin X, Li H. Obesity: Epidemiology, Pathophysiology, and Therapeutics. Front Endocrinol (Lausanne). 2021 Sep 6;12:706978. doi: 10.3389/fendo.2021.706978. PMID: 34552557; PMCID: PMC8450866.
Kahan SI. Practical Strategies for Engaging Individuals With Obesity in Primary Care. Mayo Clin Proc. 2018 Mar;93(3):351-359. doi: 10.1016/j.mayocp.2018.01.006. PMID: 29502565.
International Diabetes Federation: IDF Diabetes Atlas, 10th ed. Brussels, Belgium: 2021.
Available at: https://www.diabetesatlas.org (dostęp: 22.04.2023r.)
Traissac P, Pradeilles R, El Ati J, Aounallah-Skhiri H, Gartner A, Delpeuch F. Within-subject non-concordance of abdominal v. general high adiposity: definition and analysis issues. Br J Nutr. 2016 Aug;116(3):567-8. doi: 10.1017/S0007114516002154. Epub 2016 Jun 6. PMID: 27264990.
Wang Z, Peng Y, Dong B. Is body mass index associated with lowest mortality increasing over time? Int J Obes (Lond). 2017 Aug;41(8):1171-1175. doi: 10.1038/ijo.2017.107. Epub 2017 May 3. PMID: 28465606.
Visseren F.L.J., Mach F., Smulders Y.M. i wsp.; ESC National Cardiac Societies; ESC
Scientific Document Group: 2021 ESC Guidelines on cardiovascular disease prevention
in clinical practice. Eur. Heart J., 2021; 42: 3227–3337. doi: 10.1093/eurheartj/ehab484.
PMID: 34 458 905
Nedunchezhiyan U, Varughese I, Sun AR, Wu X, Crawford R, Prasadam I. Obesity, Inflammation, and Immune System in Osteoarthritis. Front Immunol. 2022 Jul 4;13:907750. doi: 10.3389/fimmu.2022.907750. PMID: 35860250; PMCID: PMC9289681.
Kolb R, Sutterwala FS, Zhang W. Obesity and cancer: inflammation bridges the two. Curr Opin Pharmacol. 2016 Aug;29:77-89. doi: 10.1016/j.coph.2016.07.005. Epub 2016 Jul 16. PMID: 27429211; PMCID: PMC4992602.
Pasquali R, Casanueva F, Haluzik M, van Hulsteijn L, Ledoux S, Monteiro MP, Salvador J, Santini F, Toplak H, Dekkers OM. European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity. Eur J Endocrinol. 2020 Jan;182(1):G1-G32. doi: 10.1530/EJE-19-0893. PMID: 31855556.
Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R, Plodkowski R; Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY. Endocr Pract. 2016 Jul;22 Suppl 3:1-203. doi: 10.4158/EP161365.GL. Epub 2016 May 24. PMID: 27219496.
Koliaki C, Spinos T, Spinou Μ, Brinia ΜE, Mitsopoulou D, Katsilambros N. Defining the Optimal Dietary Approach for Safe, Effective and Sustainable Weight Loss in Overweight and Obese Adults. Healthcare (Basel). 2018 Jun 28;6(3):73. doi: 10.3390/healthcare6030073. PMID: 29958395; PMCID: PMC6163457.
Semlitsch T, Stigler FL, Jeitler K, Horvath K, Siebenhofer A. Management of overweight and obesity in primary care-A systematic overview of international evidence-based guidelines. Obes Rev. 2019 Sep;20(9):1218-1230. doi: 10.1111/obr.12889. Epub 2019 Jul 8. PMID: 31286668; PMCID: PMC6852048.
Wharton S, Lau DCW, Vallis M, Sharma AM, Biertho L, Campbell-Scherer D, Adamo K, Alberga A, Bell R, Boulé N, Boyling E, Brown J, Calam B, Clarke C, Crowshoe L, Divalentino D, Forhan M, Freedhoff Y, Gagner M, Glazer S, Grand C, Green M, Hahn M, Hawa R, Henderson R, Hong D, Hung P, Janssen I, Jacklin K, Johnson-Stoklossa C, Kemp A, Kirk S, Kuk J, Langlois MF, Lear S, McInnes A, Macklin D, Naji L, Manjoo P, Morin MP, Nerenberg K, Patton I, Pedersen S, Pereira L, Piccinini-Vallis H, Poddar M, Poirier P, Prud'homme D, Salas XR, Rueda-Clausen C, Russell-Mayhew S, Shiau J, Sherifali D, Sievenpiper J, Sockalingam S, Taylor V, Toth E, Twells L, Tytus R, Walji S, Walker L, Wicklum S. Obesity in adults: a clinical practice guideline. CMAJ. 2020 Aug 4;192(31):E875-E891. doi: 10.1503/cmaj.191707. PMID: 32753461; PMCID: PMC7828878
Bansal AB, Al Khalili Y. Orlistat. 2022 Dec 11. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 31194359.
Onakpoya IJ, Lee JJ, Mahtani KR, Aronson JK, Heneghan CJ. Naltrexone-bupropion (Mysimba) in management of obesity: A systematic review and meta-analysis of unpublished clinical study reports. Br J Clin Pharmacol. 2020 Apr;86(4):646-667. doi: 10.1111/bcp.14210. Epub 2020 Feb 4. PMID: 31918448; PMCID: PMC7098870.
Mancini MC, de Melo ME. The burden of obesity in the current world and the new treatments available: focus on liraglutide 3.0 mg. Diabetol Metab Syndr. 2017 May 31;9:44. doi: 10.1186/s13098-017-0242-0. PMID: 28580018; PMCID: PMC5452636.
Kelly AS, Auerbach P, Barrientos-Perez M, Gies I, Hale PM, Marcus C, Mastrandrea LD, Prabhu N, Arslanian S; NN8022-4180 Trial Investigators. A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity. N Engl J Med. 2020 May 28;382(22):2117-2128. doi: 10.1056/NEJMoa1916038. Epub 2020 Mar 31. PMID: 32233338.
Wang JY, Wang QW, Yang XY, Yang W, Li DR, Jin JY, Zhang HC, Zhang XF. GLP-1 receptor agonists for the treatment of obesity: Role as a promising approach. Front Endocrinol (Lausanne). 2023 Feb 1;14:1085799. doi: 10.3389/fendo.2023.1085799. PMID: 36843578; PMCID: PMC9945324.
Szeliga J, Wyleżoł M, Major P, Budzyński A, Binda A, Proczko-Stepaniak M, Boniecka I, Matłok M, Sekuła M, Kaska Ł, Myśliwiec P, Szewczyk T, Możański M, Kowalski G, Pesta W, Lisik W, Michalik M, Lewandowski T, Paśnik K. Metabolic and Bariatric Surgery Chapter of the Association of Polish Surgeons. Bariatric and metabolic surgery care standards. Wideochir Inne Tech Maloinwazyjne. 2020 Sep;15(3):391-394. doi: 10.5114/wiitm.2020.97935. Epub 2020 Aug 5. PMID: 32904635; PMCID: PMC7457194.
Kim J, Eisenberg D, Azagury D, Rogers A, Campos GM. American Society for Metabolic and Bariatric Surgery position statement on long-term survival benefit after metabolic and bariatric surgery. Surg Obes Relat Dis. 2016 Mar-Apr;12(3):453-459. doi: 10.1016/j.soard.2015.11.021. Epub 2015 Nov 27. PMID: 26944548.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Ewelina Zygmunt-Siembida, Hubert Wróblewska, Aleksandra Zimna, Kinga Wróblewska, Magdalena Kozdra, Laura Piasek, Aleksandra Osińska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 628
Number of citations: 0